speb/financial-data huggingface dataset:
MEDP income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 3859000.00
MEDP balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 71573.00
MEDP balance_sheet (annual, 2022-12-31) — Treasury Stock: 12497000.00
MEDP balance_sheet (annual, 2022-12-31) — Working Capital: -469508000.00
MEDP income_statement (annual, 2023-12-31) — +Operating Expense: 187680000.00
MEDP income_statement (annual, 2023-12-31) — +Total Revenue: 1885842000.00
MEDP balance_sheet (annual, 2023-12-31) — Accounts Payable: 31869000.00
MEDP balance_sheet (annual, 2023-12-31) — Accounts Receivable: 275932000.00
MEDP balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -79404000.00
MEDP balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 802681000.00
MEDP income_statement (annual, 2023-12-31) — Amortization: 2199000.00
MEDP cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 2199000.00
MEDP cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 2199000.00
MEDP income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 2199000.00
MEDP income_statement (annual, 2023-12-31) — Basic Average Shares: 30722000.00
MEDP income_statement (annual, 2023-12-31) — Basic EPS: 9.20
MEDP cash_flow (annual, 2023-12-31) — Beginning Cash Position: 28265000.00
MEDP balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 16419000.00
MEDP cash_flow (annual, 2023-12-31) — Capital Expenditure: -36648000.00
MEDP balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 142122000.00
MEDP balance_sheet (annual, 2023-12-31) — Capital Stock: 308000.00
MEDP balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 245449000.00
MEDP balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 245449000.00
MEDP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -182642000.00
MEDP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -34629000.00
MEDP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 433374000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Account Payable: 1051000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 82080000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -18873000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 87524000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Payable: 1051000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 83131000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 2986000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Receivables: -48282000.00
MEDP cash_flow (annual, 2023-12-31) — Change In Working Capital: 106486000.00
MEDP cash_flow (annual, 2023-12-31) — Changes In Cash: 216103000.00
MEDP balance_sheet (annual, 2023-12-31) — Common Stock: 308000.00
MEDP balance_sheet (annual, 2023-12-31) — Common Stock Equity: 558950000.00
MEDP cash_flow (annual, 2023-12-31) — Common Stock Payments: -144020000.00
MEDP balance_sheet (annual, 2023-12-31) — Construction In Progress: 7182000.00
MEDP income_statement (annual, 2023-12-31) — Cost Of Revenue: 1361337000.00
MEDP balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 217139000.00
MEDP balance_sheet (annual, 2023-12-31) — Current Assets: 593828000.00
MEDP balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 559860000.00
MEDP balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 559860000.00
MEDP balance_sheet (annual, 2023-12-31) — Current Liabilities: 925131000.00
MEDP cash_flow (annual, 2023-12-31) — Deferred Income Tax: -25117000.00
MEDP cash_flow (annual, 2023-12-31) — Deferred Tax: -25117000.00
MEDP cash_flow (annual, 2023-12-31) — Depreciation: 24129000.00
MEDP cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 26328000.00
MEDP income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 26328000.00
MEDP cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 26328000.00
MEDP income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 26328000.00
MEDP income_statement (annual, 2023-12-31) — Depreciation Income Statement: 24129000.00
MEDP income_statement (annual, 2023-12-31) — Diluted Average Shares: 31841000.00
MEDP income_statement (annual, 2023-12-31) — Diluted EPS: 8.88
MEDP income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 282619000.00
MEDP income_statement (annual, 2023-12-31) — EBIT: 336825000.00
MEDP income_statement (annual, 2023-12-31) — EBITDA: 363153000.00
MEDP cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 1081000.00
MEDP cash_flow (annual, 2023-12-31) — End Cash Position: 245449000.00
MEDP cash_flow (annual, 2023-12-31) — Financing Cash Flow: -182642000.00
MEDP cash_flow (annual, 2023-12-31) — Free Cash Flow: 396726000.00
MEDP income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1929000.00
MEDP balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -10072000.00
MEDP balance_sheet (annual, 2023-12-31) — Goodwill: 662396000.00
MEDP balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 698205000.00
MEDP balance_sheet (annual, 2023-12-31) — Gross PPE: 344794000.00
MEDP income_statement (annual, 2023-12-31) — Gross Profit: 524505000.00
MEDP cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 76353000.00
MEDP cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3056000.00
MEDP balance_sheet (annual, 2023-12-31) — Invested Capital: 558950000.00
MEDP cash_flow (annual, 2023-12-31) — Investing Cash Flow: -34629000.00
MEDP cash_flow (annual, 2023-12-31) — Issuance Of Debt: 105000000.00
MEDP balance_sheet (annual, 2023-12-31) — Land And Improvements: 4833000.00
MEDP balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
MEDP balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 142122000.00
MEDP balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 142122000.00
MEDP balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 131632000.00
MEDP cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -144020000.00
MEDP income_statement (annual, 2023-12-31) — Net Income: 282810000.00
MEDP income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 282619000.00
MEDP income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 282810000.00
MEDP income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 282810000.00
MEDP income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 282810000.00
MEDP cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 282810000.00
MEDP income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 282810000.00
MEDP income_statement (annual, 2023-12-31) — Net Interest Income: -488000.00
MEDP cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -50000000.00
MEDP income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -488000.00
MEDP cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 2019000.00
MEDP balance_sheet (annual, 2023-12-31) — Net PPE: 265390000.00
MEDP cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -36648000.00
MEDP cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -50000000.00
MEDP balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -139255000.00
MEDP balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 74435000.00
MEDP balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2404000.00
MEDP balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 74435000.00
MEDP balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2404000.00
MEDP income_statement (annual, 2023-12-31) — Normalized EBITDA: 365082000.00
MEDP income_statement (annual, 2023-12-31) — Normalized Income: 284434218.00
MEDP cash_flow (annual, 2023-12-31) — Operating Cash Flow: 433374000.00
MEDP income_statement (annual, 2023-12-31) — Operating Income: 336825000.00
MEDP income_statement (annual, 2023-12-31) — Operating Revenue: 1885842000.00
MEDP balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 30752292.00
MEDP balance_sheet (annual, 2023-12-31) — Other Current Assets: 49979000.00
MEDP balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 40441000.00
MEDP balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -10072000.00
MEDP income_statement (annual, 2023-12-31) — Other Income Expense: -655000.00
MEDP balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 35809000.00
MEDP cash_flow (annual, 2023-12-31) — Other Non Cash Items: 22351000.00
MEDP balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 24970000.00
MEDP balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 28221000.00
MEDP income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1274000.00
MEDP balance_sheet (annual, 2023-12-31) — Other Properties: 184728000.00
MEDP balance_sheet (annual, 2023-12-31) — Other Receivables: 22475000.00
MEDP income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 191000.00
MEDP balance_sheet (annual, 2023-12-31) — Payables: 31869000.00
MEDP balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 249008000.00
MEDP balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 75822000.00
MEDP balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
MEDP income_statement (annual, 2023-12-31) — Pretax Income: 335682000.00
MEDP cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 11378000.00
MEDP balance_sheet (annual, 2023-12-31) — Properties: 0.00
MEDP cash_flow (annual, 2023-12-31) — Purchase Of PPE: -36648000.00
MEDP balance_sheet (annual, 2023-12-31) — Receivables: 298400000.00
MEDP balance_sheet (annual, 2023-12-31) — Receivables Adjustments Allowances: -7000.00
MEDP income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1361337000.00
MEDP income_statement (annual, 2023-12-31) — Reconciled Depreciation: 26328000.00
MEDP cash_flow (annual, 2023-12-31) — Repayment Of Debt: -155000000.00
MEDP cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -144020000.00
MEDP balance_sheet (annual, 2023-12-31) — Retained Earnings: -221645000.00
MEDP income_statement (annual, 2023-12-31) — Selling General And Administration: 161352000.00
MEDP balance_sheet (annual, 2023-12-31) — Share Issued: 30822865.00
MEDP cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 105000000.00
MEDP cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -155000000.00
MEDP cash_flow (annual, 2023-12-31) — Stock Based Compensation: 20516000.00
MEDP balance_sheet (annual, 2023-12-31) — Stockholders Equity: 558950000.00
MEDP balance_sheet (annual, 2023-12-31) — Tangible Book Value: -139255000.00
MEDP income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -304782.00
MEDP income_statement (annual, 2023-12-31) — Tax Provision: 52872000.00
MEDP income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.16
MEDP balance_sheet (annual, 2023-12-31) — Total Assets: 1656828000.00
MEDP balance_sheet (annual, 2023-12-31) — Total Capitalization: 558950000.00
MEDP balance_sheet (annual, 2023-12-31) — Total Debt: 142122000.00
MEDP balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 558950000.00
MEDP income_statement (annual, 2023-12-31) — Total Expenses: 1549017000.00
MEDP balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1097878000.00
MEDP balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1063000000.00
MEDP balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 172747000.00
MEDP income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 336825000.00
MEDP income_statement (annual, 2023-12-31) — Total Other Finance Cost: 488000.00
MEDP income_statement (annual, 2023-12-31) — Total Unusual Items: -1929000.00
MEDP income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1929000.00
MEDP balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 70573.00
MEDP balance_sheet (annual, 2023-12-31) — Treasury Stock: 12322000.00
MEDP balance_sheet (annual, 2023-12-31) — Working Capital: -331303000.00
MEDP cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
MEDP cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
MEDP cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
MEDP cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
MEDP cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: 0.00
MEDP income_statement (annual, 2024-12-31) — +Operating Expense: 209435000.00
MEDP income_statement (annual, 2024-12-31) — +Total Revenue: 2109054000.00
MEDP balance_sheet (annual, 2024-12-31) — Accounts Payable: 32528000.00
MEDP balance_sheet (annual, 2024-12-31) — Accounts Receivable: 291096000.00
MEDP balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -98869000.00
MEDP balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -98869000.00
MEDP balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 844050000.00
MEDP income_statement (annual, 2024-12-31) — Amortization: 1443000.00
MEDP cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 1443000.00
MEDP cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 1443000.00
MEDP income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 1443000.00
MEDP income_statement (annual, 2024-12-31) — Basic Average Shares: 30957000.00
MEDP income_statement (annual, 2024-12-31) — Basic EPS: 13.06
MEDP cash_flow (annual, 2024-12-31) — Beginning Cash Position: 245449000.00
MEDP balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 15815000.00
MEDP balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 15815000.00
MEDP cash_flow (annual, 2024-12-31) — Capital Expenditure: -36548000.00
MEDP balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 126234000.00
MEDP balance_sheet (annual, 2024-12-31) — Capital Stock: 306000.00
MEDP balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 669436000.00
MEDP balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 669436000.00
MEDP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -154009000.00
MEDP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -28308000.00
MEDP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 608815000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Account Payable: -2965000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 16882000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -21407000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 174519000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Payable: -2965000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 13917000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -12090000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Receivables: 2242000.00
MEDP cash_flow (annual, 2024-12-31) — Change In Working Capital: 157181000.00
MEDP cash_flow (annual, 2024-12-31) — Changes In Cash: 426498000.00
MEDP balance_sheet (annual, 2024-12-31) — Common Stock: 306000.00
MEDP balance_sheet (annual, 2024-12-31) — Common Stock Equity: 825545000.00
MEDP cash_flow (annual, 2024-12-31) — Common Stock Payments: -169867000.00
MEDP balance_sheet (annual, 2024-12-31) — Construction In Progress: 21167000.00
MEDP balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 21167000.00
MEDP income_statement (annual, 2024-12-31) — Cost Of Revenue: 1452749000.00
MEDP balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 222878000.00
MEDP balance_sheet (annual, 2024-12-31) — Current Assets: 1029229000.00
MEDP balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 710585000.00
MEDP balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 710585000.00
MEDP balance_sheet (annual, 2024-12-31) — Current Liabilities: 1104553000.00
MEDP cash_flow (annual, 2024-12-31) — Deferred Income Tax: -26632000.00
MEDP cash_flow (annual, 2024-12-31) — Deferred Tax: -26632000.00
MEDP cash_flow (annual, 2024-12-31) — Depreciation: 27808000.00
MEDP cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 29251000.00
MEDP income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 29251000.00
MEDP cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 29251000.00
MEDP income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 29251000.00
MEDP income_statement (annual, 2024-12-31) — Depreciation Income Statement: 27808000.00
MEDP income_statement (annual, 2024-12-31) — Diluted Average Shares: 32014000.00
MEDP income_statement (annual, 2024-12-31) — Diluted EPS: 12.63
MEDP income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 404342000.00
MEDP income_statement (annual, 2024-12-31) — EBIT: 446870000.00
MEDP income_statement (annual, 2024-12-31) — EBITDA: 476121000.00
MEDP cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2511000.00
MEDP cash_flow (annual, 2024-12-31) — End Cash Position: 669436000.00
MEDP cash_flow (annual, 2024-12-31) — Financing Cash Flow: -154009000.00
MEDP cash_flow (annual, 2024-12-31) — Free Cash Flow: 572267000.00
MEDP income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -496000.00
MEDP balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -14743000.00
MEDP balance_sheet (annual, 2024-12-31) — Goodwill: 662396000.00
MEDP balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 696762000.00
MEDP balance_sheet (annual, 2024-12-31) — Gross PPE: 351133000.00
MEDP income_statement (annual, 2024-12-31) — Gross Profit: 656305000.00
MEDP cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 83567000.00
MEDP cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 171000.00
MEDP balance_sheet (annual, 2024-12-31) — Invested Capital: 825545000.00
MEDP cash_flow (annual, 2024-12-31) — Investing Cash Flow: -28308000.00
MEDP cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
MEDP cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
MEDP balance_sheet (annual, 2024-12-31) — Land And Improvements: 5032000.00
MEDP balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 5032000.00
MEDP balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 126234000.00
MEDP balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 126234000.00
MEDP balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 134827000.00
MEDP balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 134827000.00
MEDP cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -169867000.00
MEDP income_statement (annual, 2024-12-31) — Net Income: 404386000.00
MEDP income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 404342000.00
MEDP income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 404386000.00
MEDP income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 404386000.00
MEDP income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 404386000.00
MEDP cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 404386000.00
MEDP income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 404386000.00
MEDP income_statement (annual, 2024-12-31) — Net Interest Income: 24996000.00
MEDP cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
MEDP cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
MEDP income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 24996000.00
MEDP cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 8240000.00
MEDP balance_sheet (annual, 2024-12-31) — Net PPE: 252264000.00
MEDP cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -36548000.00
MEDP cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -7643000.00
MEDP cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
MEDP cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
MEDP balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 128783000.00
MEDP balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 100357000.00
MEDP balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1800000.00
MEDP balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 100357000.00
MEDP balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1800000.00
MEDP income_statement (annual, 2024-12-31) — Normalized EBITDA: 476617000.00
MEDP income_statement (annual, 2024-12-31) — Normalized Income: 404807600.00
MEDP cash_flow (annual, 2024-12-31) — Operating Cash Flow: 608815000.00
MEDP income_statement (annual, 2024-12-31) — Operating Income: 446870000.00
MEDP income_statement (annual, 2024-12-31) — Operating Revenue: 2109054000.00
MEDP balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 30630799.00
MEDP balance_sheet (annual, 2024-12-31) — Other Current Assets: 63350000.00
MEDP balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 53633000.00
MEDP balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -14743000.00
MEDP income_statement (annual, 2024-12-31) — Other Income Expense: 4056000.00
MEDP balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 34366000.00
MEDP cash_flow (annual, 2024-12-31) — Other Non Cash Items: 19115000.00
MEDP balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 22254000.00
MEDP balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 42734000.00
MEDP income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 4552000.00
MEDP balance_sheet (annual, 2024-12-31) — Other Properties: 174292000.00
MEDP balance_sheet (annual, 2024-12-31) — Other Receivables: 5347000.00
MEDP income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 44000.00
MEDP income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 3000.00
MEDP balance_sheet (annual, 2024-12-31) — Payables: 32528000.00
MEDP balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 255406000.00
MEDP balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 84929000.00
MEDP balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
MEDP income_statement (annual, 2024-12-31) — Pretax Income: 475922000.00
MEDP cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 15858000.00
MEDP balance_sheet (annual, 2024-12-31) — Properties: 0.00
MEDP balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MEDP cash_flow (annual, 2024-12-31) — Purchase Of PPE: -36548000.00
MEDP cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -7643000.00
MEDP balance_sheet (annual, 2024-12-31) — Receivables: 296443000.00
MEDP balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: 0.00
MEDP income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1452749000.00
MEDP income_statement (annual, 2024-12-31) — Reconciled Depreciation: 29251000.00
MEDP cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
MEDP cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
MEDP cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -169867000.00
MEDP balance_sheet (annual, 2024-12-31) — Retained Earnings: 8167000.00
MEDP income_statement (annual, 2024-12-31) — Selling General And Administration: 180184000.00
MEDP balance_sheet (annual, 2024-12-31) — Share Issued: 30700872.00
MEDP cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
MEDP cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
MEDP cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
MEDP cash_flow (annual, 2024-12-31) — Stock Based Compensation: 25514000.00
MEDP balance_sheet (annual, 2024-12-31) — Stockholders Equity: 825545000.00
MEDP balance_sheet (annual, 2024-12-31) — Tangible Book Value: 128783000.00
MEDP income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -74400.00
MEDP income_statement (annual, 2024-12-31) — Tax Provision: 71536000.00
MEDP income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
MEDP balance_sheet (annual, 2024-12-31) — Total Assets: 2100866000.00
MEDP balance_sheet (annual, 2024-12-31) — Total Capitalization: 825545000.00
MEDP balance_sheet (annual, 2024-12-31) — Total Debt: 126234000.00
MEDP balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 825545000.00
MEDP income_statement (annual, 2024-12-31) — Total Expenses: 1662184000.00
MEDP balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1275321000.00
MEDP balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1071637000.00
MEDP balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 170768000.00
MEDP income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 446870000.00
MEDP income_statement (annual, 2024-12-31) — Total Other Finance Cost: -24996000.00
MEDP income_statement (annual, 2024-12-31) — Total Unusual Items: -496000.00
MEDP income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -496000.00
MEDP balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 70073.00
MEDP balance_sheet (annual, 2024-12-31) — Treasury Stock: 12235000.00
MEDP balance_sheet (annual, 2024-12-31) — Working Capital: -75324000.00
MEDP income_statement (quarterly, 2025-03-31) — +Operating Expense: 64827000.00
MEDP income_statement (quarterly, 2025-03-31) — +Total Revenue: 558570000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 61318000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 291893000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 886883000.00
MEDP income_statement (quarterly, 2025-03-31) — Amortization: 236000.00
MEDP cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 236000.00
MEDP cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 236000.00
MEDP income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 236000.00
MEDP income_statement (quarterly, 2025-03-31) — Basic Average Shares: 30387000.00
MEDP income_statement (quarterly, 2025-03-31) — Basic EPS: 3.77
MEDP cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 669436000.00
MEDP cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -9994000.00
MEDP cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -9994000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 126660000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Capital Stock: 298000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 441436000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 441436000.00
MEDP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -345966000.00
MEDP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -9987000.00
MEDP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 125836000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 10720000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -23160000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -6548000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 19718000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Payable: 10720000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -12440000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -17553000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2069000.00
MEDP cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -18892000.00
MEDP cash_flow (quarterly, 2025-03-31) — Changes In Cash: -230117000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Common Stock: 298000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 593609000.00
MEDP cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -371900000.00
MEDP income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 380220000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 232911000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Current Assets: 821437000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 718716000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 718716000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1122311000.00
MEDP cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 749000.00
MEDP cash_flow (quarterly, 2025-03-31) — Deferred Tax: 749000.00
MEDP cash_flow (quarterly, 2025-03-31) — Depreciation: 6694000.00
MEDP cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 6930000.00
MEDP income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 6930000.00
MEDP cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 6930000.00
MEDP income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 6930000.00
MEDP income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 6694000.00
MEDP income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 31196000.00
MEDP income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.67
MEDP income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 114595000.00
MEDP income_statement (quarterly, 2025-03-31) — EBIT: 113523000.00
MEDP income_statement (quarterly, 2025-03-31) — EBITDA: 120453000.00
MEDP cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 2117000.00
MEDP cash_flow (quarterly, 2025-03-31) — End Cash Position: 441436000.00
MEDP cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -345966000.00
MEDP cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 115842000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -11621000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Goodwill: 662396000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 696526000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Gross PPE: 258191000.00
MEDP income_statement (quarterly, 2025-03-31) — Gross Profit: 178350000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Invested Capital: 593609000.00
MEDP cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -9987000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 126660000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 126660000.00
MEDP cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -371900000.00
MEDP income_statement (quarterly, 2025-03-31) — Net Income: 114595000.00
MEDP income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 114595000.00
MEDP income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 114595000.00
MEDP income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 114595000.00
MEDP income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 114595000.00
MEDP cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 114595000.00
MEDP income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 114595000.00
MEDP income_statement (quarterly, 2025-03-31) — Net Interest Income: 6463000.00
MEDP income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 6463000.00
MEDP cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 7000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Net PPE: 258191000.00
MEDP cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -9994000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -102917000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 99692000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1838000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 99692000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1838000.00
MEDP income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 120453000.00
MEDP income_statement (quarterly, 2025-03-31) — Normalized Income: 114595000.00
MEDP cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 125836000.00
MEDP income_statement (quarterly, 2025-03-31) — Operating Income: 113523000.00
MEDP income_statement (quarterly, 2025-03-31) — Operating Revenue: 558570000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 29836211.00
MEDP balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 81784000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 56178000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -11621000.00
MEDP income_statement (quarterly, 2025-03-31) — Other Income Expense: -1816000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 34130000.00
MEDP cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 5562000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 21523000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 52951000.00
MEDP income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -1816000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Other Properties: 258191000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Other Receivables: 6324000.00
MEDP income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDP balance_sheet (quarterly, 2025-03-31) — Payables: 61318000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 294229000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 53188000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
MEDP income_statement (quarterly, 2025-03-31) — Pretax Income: 118170000.00
MEDP cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 25934000.00
MEDP cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -9994000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Receivables: 298217000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: 0.00
MEDP income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 380220000.00
MEDP income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6930000.00
MEDP cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -371900000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -269716000.00
MEDP income_statement (quarterly, 2025-03-31) — Selling General And Administration: 57897000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Share Issued: 29906284.00
MEDP cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 16892000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 593609000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -102917000.00
MEDP income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MEDP income_statement (quarterly, 2025-03-31) — Tax Provision: 3575000.00
MEDP income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.03
MEDP balance_sheet (quarterly, 2025-03-31) — Total Assets: 1897369000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 593609000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Total Debt: 126660000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 593609000.00
MEDP income_statement (quarterly, 2025-03-31) — Total Expenses: 445047000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1303760000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1075932000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 181449000.00
MEDP income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 113523000.00
MEDP income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -6463000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 70073.00
MEDP balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 12235000.00
MEDP balance_sheet (quarterly, 2025-03-31) — Working Capital: -300874000.00
MEDP income_statement (quarterly, 2025-06-30) — +Operating Expense: 53678000.00
MEDP income_statement (quarterly, 2025-06-30) — +Total Revenue: 603311000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 43275000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 371918000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 893174000.00
MEDP income_statement (quarterly, 2025-06-30) — Amortization: 237000.00
MEDP cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 237000.00
MEDP cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 237000.00
MEDP income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 237000.00
MEDP income_statement (quarterly, 2025-06-30) — Basic Average Shares: 28601000.00
MEDP income_statement (quarterly, 2025-06-30) — Basic EPS: 3.16
MEDP cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 441436000.00
MEDP cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -6113000.00
MEDP cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -6113000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 124946000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Capital Stock: 281000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 46330000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 46330000.00
MEDP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -540564000.00
MEDP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -6020000.00
MEDP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 148526000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1301000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 35409000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -6067000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 70434000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Payable: 1301000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 36710000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -15577000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Receivables: -79911000.00
MEDP cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 5589000.00
MEDP cash_flow (quarterly, 2025-06-30) — Changes In Cash: -398058000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Common Stock: 281000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 172351000.00
MEDP cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -540915000.00
MEDP income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 423298000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 255267000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Current Assets: 520805000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 808783000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 808783000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1220443000.00
MEDP cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 34107000.00
MEDP cash_flow (quarterly, 2025-06-30) — Deferred Tax: 34107000.00
MEDP cash_flow (quarterly, 2025-06-30) — Depreciation: 6777000.00
MEDP cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7014000.00
MEDP income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 7014000.00
MEDP cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7014000.00
MEDP income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 7014000.00
MEDP income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 6777000.00
MEDP income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 29143000.00
MEDP income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.10
MEDP income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 90260000.00
MEDP income_statement (quarterly, 2025-06-30) — EBIT: 126335000.00
MEDP income_statement (quarterly, 2025-06-30) — EBITDA: 133349000.00
MEDP cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 2952000.00
MEDP cash_flow (quarterly, 2025-06-30) — End Cash Position: 46330000.00
MEDP cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -540564000.00
MEDP cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 142413000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -5654000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Goodwill: 662396000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 696289000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Gross PPE: 264985000.00
MEDP income_statement (quarterly, 2025-06-30) — Gross Profit: 180013000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Invested Capital: 172351000.00
MEDP cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -6020000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 124946000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 124946000.00
MEDP cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -540915000.00
MEDP income_statement (quarterly, 2025-06-30) — Net Income: 90260000.00
MEDP income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 90260000.00
MEDP income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 90260000.00
MEDP income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 90260000.00
MEDP income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 90260000.00
MEDP cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 90260000.00
MEDP income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 90260000.00
MEDP income_statement (quarterly, 2025-06-30) — Net Interest Income: 1078000.00
MEDP income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 1078000.00
MEDP cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 93000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Net PPE: 264985000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -523938000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 65792000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2016000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 65792000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2016000.00
MEDP income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 133349000.00
MEDP income_statement (quarterly, 2025-06-30) — Normalized Income: 90260000.00
MEDP cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 148526000.00
MEDP income_statement (quarterly, 2025-06-30) — Operating Income: 126335000.00
MEDP income_statement (quarterly, 2025-06-30) — Operating Revenue: 603311000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 28088626.00
MEDP balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 96554000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 44880000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -5654000.00
MEDP income_statement (quarterly, 2025-06-30) — Other Income Expense: -2875000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 33893000.00
MEDP cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 5605000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 23802000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 51917000.00
MEDP income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -2875000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Other Properties: 264985000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Other Receivables: 6003000.00
MEDP income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MEDP balance_sheet (quarterly, 2025-06-30) — Payables: 43275000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 298542000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 68238000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
MEDP income_statement (quarterly, 2025-06-30) — Pretax Income: 124538000.00
MEDP cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 351000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Receivables: 377921000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: 0.00
MEDP income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 423298000.00
MEDP income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7014000.00
MEDP cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -540915000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -703215000.00
MEDP income_statement (quarterly, 2025-06-30) — Selling General And Administration: 46664000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Share Issued: 28158699.00
MEDP cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5951000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 172351000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -523938000.00
MEDP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MEDP income_statement (quarterly, 2025-06-30) — Tax Provision: 34278000.00
MEDP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
MEDP balance_sheet (quarterly, 2025-06-30) — Total Assets: 1571673000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 172351000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Total Debt: 124946000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 172351000.00
MEDP income_statement (quarterly, 2025-06-30) — Total Expenses: 476976000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1399322000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1050868000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 178879000.00
MEDP income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 126335000.00
MEDP income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -1078000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 70073.00
MEDP balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 12235000.00
MEDP balance_sheet (quarterly, 2025-06-30) — Working Capital: -699638000.00
MEDP income_statement (quarterly, 2025-09-30) — +Operating Expense: 55131000.00
MEDP income_statement (quarterly, 2025-09-30) — +Total Revenue: 659903000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 26523000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 362318000.00